Deutsche Bank’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Deutsche Bank’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-500	Closed	-$8K	–	6501
2014 Q4	$8K	Hold	500	–	–	﹤0.01%	5781
2014 Q3	$5K	Buy	+500	New	+$3.41K	﹤0.01%	5554

Deutsche Bank's AVNR Position: Q1 2015 in Review

Deutsche Bank sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,061,123 shares — an estimated $18M sold.

Deutsche Bank first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $18M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Deutsche Bank reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Deutsche Bank sold 1,061,123 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $18M.
Deutsche Bank first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Deutsche Bank's AVANIR PHARMACEUTICALS, INC CL A position peaked at $18M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Deutsche Bank's 13F filing for Q1 2015, filed 15 May 2015.